Gleneagles Hospital Kengeri and Medulance launch South India’s first 5G-enabled ambulance service

New Delhi: Gleneagles BGS Hospital, Kengeri has introduced South India’s first 5G-enabled ambulance service in collaboration with Medulance. This initiative signifies a major leap forward in emergency medical response, utilizing state-of-the-art technology to deliver superior patient care.

In its initial phase, the service will deploy five 5G-enabled ambulances within the immediate vicinity of the hospital. The second phase will expand the fleet with five additional ambulances, extending coverage to neighboring districts, thereby bolstering emergency response capabilities throughout the region.

These 5G-enabled ambulances, equipped with high-speed connectivity provided by Reliance Jio, facilitate real-time audio and video communication. They also feature cameras and smart devices for high-definition footage transmission, coupled with Advanced Life Support (ALS) systems for critical medical interventions. The ambulances enable real-time streaming of patient health data to remote doctors and transmit vital signs to emergency room dashboards. Additionally, they include ambulance location tracking for efficient dispatch and navigation, as well as remote monitoring capabilities allowing doctors to guide paramedics.

The enhanced connectivity and real-time data relay significantly reduce response times to less than four minutes in corporate settings. Patients benefit from immediate clinical assessment and medical intervention during transit, supported by remote assistance from doctors. This use of the ‘Golden Hour’ and ‘Platinum 10 Minutes’ for critical care markedly improves survival rates in emergencies such as heart attacks and strokes.

Furthermore, these ambulances enhance healthcare access in rural and remote areas and facilitate seamless data sharing with hospitals to prepare for incoming patients. The higher bandwidth and ultra-low latency of the 5G network ensure efficient data transfer, while integration with corporate wellness programs helps reduce healthcare costs and improve employee health outcomes.

Pranav Bajaj, Co-founder and CEO of Medulance, highlighted, “Our 5G- enabled ambulances, in partnership with Gleneagles BGS Hospital, Kengeri, will set a new standard for patient care. With cutting-edge technology, we’re bridging the gap between emergency and treatment, ensuring timely and informed care. This innovation is a testament to our commitment to saving lives and shaping the future of healthcare.’

Ravjot Singh Arora, Co-founder and COO of Medulance, expressed, “The launch of 5G-enabled ambulances is a dream come true for us. We’ve always envisioned a future where technology meets healthcare to save lives. With this innovation, we’re empowering paramedics, doctors, and patients to connect in real time, making emergency response more efficient and effective. We’re proud to be at the forefront of this revolution in healthcare.”

Anurag Yadav, CEO of Gleneagles India, shared, “We are thrilled to introduce the first 5G-enabled ambulance service in South India. This initiative is part of our larger strategy to revolutionize emergency medical services across all Gleneagles hospitals, ensuring that we provide the highest level of care to our patients.”

Biju Nair, CEO of Gleneagles Bengaluru Cluster, emphasized, “Achieving excellence in emergency care is a cornerstone of our mission at Gleneagles Bengaluru. The introduction of 5G-enabled ambulances is significantly enhancing our ability to provide immediate, high-quality medical intervention, setting a new standard for emergency response in the region.”

The launch event featured prominent figures including Sri Prakashnath Swamiji, Managing Director of BGS & SJB Group of Institutions; Anita B Haddannavar, IPS, Deputy Commissioner of Police, Traffic West Division, Bengaluru City; Anurag Yadav, CEO of Gleneagles India; Biju Nair, CEO of Gleneagles Bengaluru Cluster; Ravjot Singh Arora, Co-founder and COO of Medulance; Pranav Bajaj, Co-founder and CEO of Medulance; and Namita Thapar, Executive Director of Emcure Pharmaceuticals and Investor in Medulance.